期刊： MOLECULAR PHARMACEUTICS, 2023; 20 (1)
The treatment of subcutaneous abscesses has been greatly hindered due to the spread of drug-resistant strains such as methicillin-resistant Staphyloco......
期刊： MOLECULAR PHARMACEUTICS, 2023; 20 (2)
Tumor-associated macrophages (TAMs) possess great potential in the development of ovarian cancer (OC). Aberrant GATA-binding protein-3 (GATA3) express......
期刊： MOLECULAR PHARMACEUTICS, 2023; ()
While the efficacy of anticancer drugs is hampered by low bioavailability and systemic toxicity, the uncertainty remains whether encapsulation of thes......
期刊： MOLECULAR PHARMACEUTICS, 2023; 20 (2)
Small-molecule drugs have been employed for years as therapeutics in the pharmaceutical industry. However, small-molecule drugs typically have short i......
期刊： MOLECULAR PHARMACEUTICS, 2023; ()
The C-H bond dissociation energy (BDE) of drug molecules is often used to estimate their relative propensities to undergo autoxidation. BDE calculatio......
期刊： MOLECULAR PHARMACEUTICS, 2023; 20 (4)
Co-crystal design is a convenient way to remedy the poor biopharmaceutical properties of drugs. Most studies focus on experimental co-crystal screenin......
期刊： MOLECULAR PHARMACEUTICS, 2023; 20 (6)
Preparation of the ionic liquid (IL) form of active pharmaceutical ingredients (APIs), termed API-IL, has attracted attention because it can improve u......
期刊： MOLECULAR PHARMACEUTICS, 2023; 20 (9)
This study is designed to compare drug encapsulation by cucurbit[7]uril and beta-cyclodextrin, using fluorofenidone as a model drug. Single-crystal X-......
期刊： MOLECULAR PHARMACEUTICS, 2023; 20 (10)
Multidrug salts represent more than one drug in a crystal lattice and thus could be used to deliver multiple drugs in a single dose. It showcases uniq......
期刊： MOLECULAR PHARMACEUTICS, 2023; 20 (10)
Cardiovascular diseases (CVDs) refer to a collection of conditions characterized by abnormalities in the cardiovascular system. They are a global prob......
期刊： MOLECULAR PHARMACEUTICS, 2023; 20 (10)
Cubosomes are nanoparticles with bicontinuous cubic internal nanostructures that have been considered for use in drug delivery systems (DDS). However,......
期刊： MOLECULAR PHARMACEUTICS, 2023; 20 (11)
The integration of the lipid nanoparticle (LNP)-protein corona as a pioneering approach for the development of vaccines against the present and future......
期刊： MOLECULAR PHARMACEUTICS, 2023; 20 (11)
Mucopolysaccharidoses (MPSs) make up a group of lysosomal storage diseases characterized by the aberrant accumulation of glycosaminoglycans throughout......
